Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: A multicenter cohort study (SEVEN-UP)

Ophthalmology

Volumn 120, Issue 11, 2013, Pages 2292-2299

  Rofagha, Soraya ^a   Bhisitkul, Robert B ^a   Boyer, David S ^b   Sadda, Srinivas R ^c   Zhang, Kang ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI VASCULOTROPIN ANTIBODY; BEVACIZUMAB; RANIBIZUMAB; STEROID; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ARTICLE; AUTOFLUORESCENCE IMAGING; CHILD; CLINICAL EVALUATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EXPERIMENTAL THERAPY; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINAL THICKNESS; SCHOOL CHILD; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MALE; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84887150456     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.03.046     Document Type: Article

References (16)

1. Macular Photocoagulation Study Group Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials Arch Ophthalmol 111 1993 1200 1209
2. T.Y. Wong, U. Chakravarthy, and R. Klein The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis Ophthalmology 115 2008 116 126
3. D. Pauleikhoff Neovascular age-related macular degeneration: natural history and treatment outcomes Retina 25 2005 1065 1084
4. A.R. Shah, and L.V. Del Priore Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration Ophthalmology 116 2009 1901 1907
5. P.J. Rosenfeld, A.A. Moshfeghi, and C.A. Puliafito Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmic Surg Lasers Imaging 36 2005 331 335
6. D.M. Brown, M. Michels, and P.K. Kaiser Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study Ophthalmology 116 2009 57 65
7. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
8. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
9. CATT Research Group Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 2011 1897 1908
10. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group D.F. Martin, M.G. Maguire, and S.L. Fine Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 2012 1388 1398
11. J.S. Heier, D.M. Brown, V. Chong VIEW 1 and VIEW 2 Study Groups Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration Ophthalmology 119 2012 2537 2548
12. IVAN Study Investigators U. Chakravarthy, S.P. Harding, and C.A. Rogers Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial Ophthalmology 119 2012 1399 1411
13. M.A. Singer, C.C. Awh, and S. Sadda HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration Ophthalmology 119 2012 1175 1183
14. A.N. Antoszyk, L. Tuomi, C.Y. Chung, A. Singh FOCUS Study Group Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results Am J Ophthalmol 145 2008 862 874
15. F.L. Ferris III, and I. Bailey Standardizing the measurement of visual acuity for clinical research studies: guidelines from the Eye Care Technology Forum Ophthalmology 103 1996 181 182
16. O.P. Gupta, G. Shienbaum, and A.H. Patel A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration: clinical and economic impact Ophthalmology 117 2010 2134 2140